The manufacturers of the machines that run our DNA are still very much in the forefront, gaining investors with DNA sequencing. BD NEW YORK (GenomeWeb News) – Menlo Park, Calif.-based Pacific Biosciences today said that it recently received $20 million in funding from new investor Blackstone Cleantech...
After all the recent news about the PSA test, here's a genomics answer. The MD Anderson Cancer Center, demonstrated a very high success rate for identifying the presence of Grade 3 or higher prostate cancer cells. The new prostate cancer test will be performed at Clarient's Clinical...
Posted to
The Medical Quack .... by Barbara Duck
on 08-07-2008
Filed under: Medically Related, Technology, Pharma/FDA News, Other Items of Interest, personalized medicine, DNA, Genomics, Prostate Cancer, Pharmacogenomics, PSA, Cancer Test
One CEO comes out and states how biotech will be the new focus for Glaxo, as in a related story whereby patients will require genetic testing for their AIDS drug, Ziagen. In the future I’m sure there will be more about big pharma and their biotech strategies as personalized medicine continues...
Pfizer is wasting no time to get the calculations running and numbers rolling. To stay in the market, they are attempting to find out as much as they can about potential side effects and other perhaps adverse affects of their drugs. Better than they find up them front, as it will make for better...
Posted to
The Medical Quack .... by Barbara Duck
on 07-15-2008
Filed under: Medically Related, Technology, Pharma/FDA News, personalized medicine, DNA, drugs, Biotech, Pharmacogenomics, Side Effects
Intel and other venture capitalists seem to like the genomics business too. Personalized medicine holds the key to many areas of Pharmacogenomics and where healthcare is headed. Genomic sequencing stands to unlock many areas of information that will lead us to which drugs and combinations...
Posted to
The Medical Quack .... by Barbara Duck
on 07-15-2008
Filed under: Medically Related, Technology, personalized medicine, DNA, Genomics, Intel, Investors, Venture Capitolists, Pharmacogenomics
We all recently heard about the warning letters sent from the state of California to firms selling online personal DNA sequencing over the Internet, and requiring a physician’s prescription for the service. One company DeCode, has taken the letter to heart and is revising their marketing plant...
Posted to
The Medical Quack .... by Barbara Duck
on 07-12-2008
Filed under: Medically Related, Insurance, Pharma/FDA News, personalized medicine, DNA, Genomics, Sequence, Pharmacogenomics, Diagnostics, CPT, DeCode
When will it start paying the bills? The science and development is somewhat fragmented like the rest of health care, and this is not to say in any way that phenomenal breakthroughs are not occurring by any means as they are. Part of the problem is having enough data, real time data for one...
Posted to
The Medical Quack .... by Barbara Duck
on 07-03-2008
Filed under: Medically Related, Technology, Insurance, My Commentaries, Physician, personalized medicine, DNA, Genomics, healthcare, Science, Pharmacogenomics